Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Elstein

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Molecular Genetics and Metabolism|August 31, 2017
Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trialsDeborah Elstein, Björn Mellgard, Quinn Dinh, et al.
Archives of Gynecology and Obstetrics|September 18, 2014
The effects of maternal age and parity on maternal and neonatal outcomeMichael S Schimmel, Ruben Bromiker, Cathy Hammerman, et al.
Orphanet Journal of Rare Diseases|July 21, 2023
A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiativeTanya Collin-Histed, Madeline Stoodley, Kathleen Beusterien, et al.
Rheumatology International|March 5, 2008
Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone densityEfrat Arnheim, Gaya Chicco, Mici Phillips, et al.
Blood|March 20, 2010
Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experienceAri Zimran, Gheona Altarescu, Mici Philips, et al.
Molecular Genetics and Metabolism|September 12, 2016
Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher diseaseDeborah Elstein, T Andrew Burrow, Joel Charrow, et al.
Journal of Inherited Metabolic Disease|January 6, 2010
Disease severity in sibling pairs with type 1 Gaucher diseaseDeborah Elstein, Ayelet Gellman, Gheona Altarescu, et al.
Blood Cells, Molecules & Diseases|January 25, 2011
Glucocerebrosidase gene has an alternative upstream promoter, which has features and expression characteristic of housekeeping genesEva Svobodová, Lenka Mrázová, Ondřej Lukšan, et al.
American Journal of Hematology|April 1, 2004
Rheological determinants in patients with Gaucher disease and internal inflammationAri Zimran, Amir Bashkin, Deborah Elstein, et al.
American Journal of Medical Genetics|July 13, 2002
C7 complement deficiency in an Israeli Arab villageDoron Behar, Menachem Schlesinger, David Halle, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Molecular Genetics and Metabolism|August 31, 2017
Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trialsDeborah Elstein, Björn Mellgard, Quinn Dinh, et al.
Archives of Gynecology and Obstetrics|September 18, 2014
The effects of maternal age and parity on maternal and neonatal outcomeMichael S Schimmel, Ruben Bromiker, Cathy Hammerman, et al.
Orphanet Journal of Rare Diseases|July 21, 2023
A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiativeTanya Collin-Histed, Madeline Stoodley, Kathleen Beusterien, et al.
Rheumatology International|March 5, 2008
Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone densityEfrat Arnheim, Gaya Chicco, Mici Phillips, et al.
Blood|March 20, 2010
Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experienceAri Zimran, Gheona Altarescu, Mici Philips, et al.
Molecular Genetics and Metabolism|September 12, 2016
Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher diseaseDeborah Elstein, T Andrew Burrow, Joel Charrow, et al.
Journal of Inherited Metabolic Disease|January 6, 2010
Disease severity in sibling pairs with type 1 Gaucher diseaseDeborah Elstein, Ayelet Gellman, Gheona Altarescu, et al.
Blood Cells, Molecules & Diseases|January 25, 2011
Glucocerebrosidase gene has an alternative upstream promoter, which has features and expression characteristic of housekeeping genesEva Svobodová, Lenka Mrázová, Ondřej Lukšan, et al.
American Journal of Hematology|April 1, 2004
Rheological determinants in patients with Gaucher disease and internal inflammationAri Zimran, Amir Bashkin, Deborah Elstein, et al.
American Journal of Medical Genetics|July 13, 2002
C7 complement deficiency in an Israeli Arab villageDoron Behar, Menachem Schlesinger, David Halle, et al.
Pageof 16